Stocks Rated
SHOWING 3 OF 3
ATYR aTyr Pharma, Inc. Neutral ▼ DOWNGRADE Sep 15, 2025
BTAI BioXcel Therapeutics, Inc. Buy = MAINTAIN Jul 15, 2025
INMB INmune Bio, Inc. Buy ▲ UPGRADE Mar 11, 2026SHOWING 1–3 OF 3 STOCKS RATED
1
Stock Taper ← Back to Analysts 
RATING FIRM
LUCID CAPITAL MARKETS
3 ratings across 3 stocks
RATING MIX
ACROSS THE 3 SHOWN
BUY 2
HOLD 1
SELL 0
LAST ACTION
Maintain 1
Upgrade 1
Downgrade 1
ATYR aTyr Pharma, Inc. Neutral ▼ DOWNGRADE Sep 15, 2025 BTAI BioXcel Therapeutics, Inc. Buy = MAINTAIN Jul 15, 2025 INMB INmune Bio, Inc. Buy ▲ UPGRADE Mar 11, 2026